{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:30:52Z","timestamp":1792467052468,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>NFKB1 haploinsufficiengcy was first described in 2015 in three families with common variable immunodeficiency (CVID), presenting heterogeneously with symptoms of increased infectious susceptibility, skin lesions, malignant lymphoproliferation and autoimmunity. The described mutations all led to a rapid degradation of the mutant protein, resulting in a p50 haploinsufficient state. Since then, more than 50 other mutations have been reported, located throughout different domains of NFKB1 with the majority situated in the N-terminal Rel homology domain (RHD). The clinical spectrum has also expanded with possible disease manifestations in almost any organ system. In silico prediction tools are often used to estimate the pathogenicity of NFKB1 variants but to prove causality between disease and genetic findings, further downstream functional validation is required. In this report, we studied 2 families with CVID and two novel variants in <jats:italic>NFKB1<\/jats:italic> (c.1638-2A&amp;gt;G and c.787G&amp;gt;C). Both mutations affected mRNA and\/or protein expression of NFKB1 and resulted in excessive NLRP3 inflammasome activation in patient macrophages and upregulated interferon stimulated gene expression. Protein-protein interaction analysis demonstrated a loss of interaction with NFKB1 interaction partners for the p.V263L mutation. In conclusion, we proved pathogenicity of two novel variants in <jats:italic>NFKB1<\/jats:italic> in two families with CVID characterized by variable and incomplete penetrance.<\/jats:p>","DOI":"10.3389\/fimmu.2022.973543","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:31:10Z","timestamp":1663648270000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Common variable immunodeficiency in two kindreds with heterogeneous phenotypes caused by novel heterozygous NFKB1 mutations"],"prefix":"10.3389","volume":"13","author":[{"given":"Frederik","family":"Staels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"De Keukeleere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Kinnunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salla","family":"Keskitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaminia","family":"Lorenzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel","family":"Vanmeert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Prezzemolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Pasciuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveline","family":"Lescrinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Bossuyt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Gerbaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathijs","family":"Willemsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julika","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sien","family":"Van Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anniek","family":"Corveleyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Willekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Stalmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Meyts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Liston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Humblet-Baron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikko","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Varjosalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Schrijvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1042\/BJ20040544","article-title":"Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology","volume":"382","author":"Beinke","year":"2004","journal-title":"Biochem J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a000034","article-title":"The NF-kappaB family of transcription factors and its regulation","volume":"1","author":"Oeckinghaus","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.2MR0520-166R","article-title":"Mendelian diseases of dysregulated canonical NF-\u03baB signaling: From immunodeficiency to inflammation","volume":"108","author":"Schnappauf","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ajhg.2015.07.008","article-title":"Haploinsufficiency of the NF-\u03baB1 subunit p50 in common variable immunodeficiency","volume":"97","author":"Fliegauf M","year":"2015","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2019.11.051","article-title":"Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations","volume":"146","author":"Lorenzini","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: Amino-Acid-Specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02770","article-title":"Novel TMEM173 mutation and the role of disease modifying alleles","volume":"10","author":"Keskitalo","year":"2019","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu","year":"2017","journal-title":"Signal Transduct Target Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-020-0365-x","article-title":"Combined proximity labeling and affinity purification-mass spectrometry workflow for mapping and visualizing protein interaction networks","volume":"15","author":"Liu","year":"2020","journal-title":"Nat Protoc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.2009.05042.x","article-title":"FIH-dependent asparaginyl hydroxylation of ankyrin repeat domain-containing proteins","volume":"1177","author":"Cockman","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0606877103","article-title":"Posttranslational hydroxylation of ankyrin repeats in IkappaB proteins by the hypoxia-inducible factor (HIF) asparaginyl hydroxylase, factor inhibiting HIF (FIH)","volume":"103","author":"Cockman","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.1.289","article-title":"Human notch-1 inhibits NF-kappa b activity in the nucleus through a direct interaction involving a novel domain","volume":"167","author":"Wang","year":"2001","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.06.050","article-title":"Nuclear factor \u03baB mutations in human subjects: The devil is in the details","volume":"142","author":"Fliegauf","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2011.0028","article-title":"The role of nuclear factor \u03baB in the interferon response","volume":"31","author":"Pfeffer","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2016.10.054","article-title":"Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes","volume":"140","author":"Kaustio","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.669906","article-title":"Defining the role of nuclear factor (NF)-\u03baB p105 subunit in human macrophage by transcriptomic analysis of NFKB1 knockout THP1 cells","volume":"12","author":"Somma","year":"2021","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803637","article-title":"NF-kappa B1 p105 regulates T cell homeostasis and prevents chronic inflammation","volume":"182","author":"Chang","year":"2009","journal-title":"J Immunol (Baltimore Md: 1950)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor \u03baB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.clim.2016.11.012","article-title":"NFKB1 regulates human NK cell maturation and effector functions","volume":"175","author":"Lougaris","year":"2017","journal-title":"Clin Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1204868","article-title":"Transcription of the RelB gene is regulated by NF-kappaB","volume":"20","author":"Bren","year":"2001","journal-title":"Oncogene"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2012.12.029","article-title":"RelB\/p50 regulates TNF production in LPS-stimulated dendritic cells and macrophages","volume":"61","author":"Gasparini","year":"2013","journal-title":"Cytokine"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.973543\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T04:31:15Z","timestamp":1663648275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.973543\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2022.973543"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.973543","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"article-number":"973543"}}